We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Supernus Pharmaceuticals Inc | NASDAQ:SUPN | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 0.29 | 0.96% | 30.39 | 42,114 | 14:45:35 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 30.24 | 30.40 | 30.39 | 29.99 | 30.15 | |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 609.04M | 1.32M | 0.0240 | - | 1.65B |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| 14:46:38 | 10 | 30.345 | USD |
| Date | Time | Source | Headline |
|---|---|---|---|
| 09/10/2023 | 22:45 | DJN | Supernus Resubmits NDA to FDA for Apomorphine Infusion Device to Treat.. |
Supernus Pharmaceuticals (SUPN) Share Charts1 Year Supernus Pharmaceuticals Chart |
|
1 Month Supernus Pharmaceuticals Chart |
Intraday Supernus Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
